To confirm that D6 preferentially targets L858R/T790M-EGFR in NSCLC, we asked which architecture of EGFR is indispensable in response to D6, i.e., L858R, T790M alone or both; we also investigated if the observed effects are cell-type specific. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.